Xtx Topco LTD Immix Biopharma, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.81 - $3.06 $62,506 - $105,674	-34,534 Reduced 66.16%	17,663 $34,000
Q1 2024 May 13, 2024	BUY	$2.64 - $6.68 $137,800 - $348,675	52,197 New	52,197 $160,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.97 $16,889 - $38,586	-12,992 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.86 - $6.75 $24,165 - $87,696	12,992 New	12,992 $31,000

4.53M

8.9K

1.2K

Ticker IMMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,910,100
Market Cap $22.1M
Description
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.